Hamilton, HM -- (SBWIRE) -- 03/13/2013 -- PennyStockWatchMan.com is an investment community with a special focus on updating investors winning trading ideas, and issues Stock Alert on the stocks that run high. Today our focus is on following stocks, Kat Gold holdings Corp (PINK:BVIG), Advanced Cell Technology, Inc (OTC:ACTC), DHS Holding Co (PINK:DHSM), RXi Pharmaceuticals Corp (OTC:RXII)
Kat Gold holdings Corp(PINK:BVIG) decreased -36.92% and closed at $0.0041 on a traded volume of 4.29 million shares in comparison of 63,831.00shares of average trading volume. So far this year, the stock is down over -94.14%.
The company has a total market capitalization of $1.90 million, and its total outstanding shares are 464.48 million. Kat Gold Holdings Corp., a development stage company, engages in the acquisition, exploration, and development of mineral properties, primarily gold in Canada.
Has BVIG Found The Bottom and Ready To Move Up? Find Out Here
Advanced Cell Technology, Inc(OTC:ACTC) plunged -0.53% and closed at $0.0746 on a traded volume of 4.21 million shares whereas its average trading volume is 7.62 million shares. In the last three months, the stock is up 26.23%. The Intra-day range for the stock is $0.07 and $0.08. Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic, induced pluripotency, and adult stem cell technology in the field of regenerative medicine.
Has ACTC Found The Bottom And Ready To Gain Momentum? Find Out Here
DHS Holding Co(PINK:DHSM) dropped down -7.69% and closed at $0.0036. So far in three months, the stock is down -89.71%. The 52-week range for the stock is $0.00 and $1.02. Its overall traded volume of 3.95 million shares.DHS Holding, Co. does not have significant operations. The company focuses on pursuing mergers and acquisitions of companies. It intends to develop and expand domestic and international opportunities in multimedia, publishing, and land development.
Why Should Investors Buy DHSM After the Recent Fall? Just Go Here and Find Out
RXi Pharmaceuticals Corp(OTC:RXII)after opening its shares at the price of $0.27, dropped -10.91% to close at $0.245 for the day. The stock moved on a traded volume of 3.93 million shares in comparison of 930,642.00 shares of average trading volume.
The 52-week range for the stock is $0.03 and $0.30, and during previous trading session stocks touched its highest price at $0.30. RXi Pharmaceuticals Corporation discovers, develops, and commercializes therapies based on its RNAi platform. It provides RXI-109, a self-delivering RNAi compound (sd-rxRNA) for the reduction of dermal scarring in planned surgeries.
Will RXII Get Buyers Even After The Recent Rally? Find Out Here
PennyStockWatchMan.com goal is simple: pick stocks poised to move explosively and present them to you. We dive in and out of promo/momo campaigns, play on disruptive news, sniff out unusual trading activity like insiders buying, and have a large network of traders, promoters and savvy players that give us a proprietary edge over any other penny stock site. Our edge is your edge. Go ahead and sign-up to our competitor’s alerts. When they fail, come back and see how we make money with penny stocks.
First things first – before viewing any of our information or subscribing to our alerts, you agree and fully understand that financial markets contain risk. That being said and agreed upon, if you directly or indirectly use the information on this website or this site’s newsletters or Press Release issued by us. You shall not hold PennyStockWatchman.com or any of its affiliates liable for any loss, injury, or damage resulting from the use of this website or newsletters emanating from this website.
Please read our full disclaimer at http://www.pennystockwatchman.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)